Rankings
▼
Calendar
AVBP Q4 2022 Earnings — ArriVent BioPharma, Inc. Common Stock Revenue & Financial Results | Market Cap Arena
AVBP
ArriVent BioPharma, Inc. Common Stock
$1B
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$10M
Net Income
-$10M
EPS (Diluted)
$-0.31
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$16M
Free Cash Flow
-$16M
Stock-Based Comp.
$113,000
Balance Sheet
Total Assets
$183M
Total Liabilities
$8M
Stockholders' Equity
$174M
Cash & Equivalents
$163M
← FY 2022
All Quarters
Q1 2023 →
